1. Shepard, D., and Thompson, M.,A Cost-effectiveness Analysis of the Health Accounting Project, Staff Report, Center for the Analysis of Health Practices, Harvard School of Public Health, 1978.
2. Bertram, D., and Brooks, P., The evaluation of continuing medical education: A literature review.Health Educ. Monogr. 5 (4): 1–33, 1977.
3. American Medical Association Department of Drugs,AMA Drug Evaluations, Acton, Massachusetts, Publishing Sciences Group, 1973, pp. 325–338.
4. Prien, R., and Caffrey, E.,Guidelines for Antipsychotic Drug Use, VA Central Neuropsychiatric Research Report, No. 95, Perry Point, Maryland, 1974, pp. 8–9.
5. Shader, R.I., Appleton, W.S., and DiMascio, A., Ophthalmological (pigmentary) changes, inPsychotropic Drug Side Effects, (Shader and DiMascio, eds.), Baltimore, Williams and Wilkins, 1970, pp. 107–116.